Overview

Addition of Aromatase at the Navelbine in Pretreated Metastatic Breast Cancer.

Status:
Terminated
Trial end date:
2017-05-15
Target enrollment:
Participant gender:
Summary
The CHEOPS study aims to confirm the clinical benefit of a combination of an anti-aromatase and metronomic chemotherapy treatment
Phase:
Phase 2
Details
Lead Sponsor:
ARCAGY/ GINECO GROUP
Collaborator:
Pierre Fabre Laboratories
Treatments:
Anastrozole
Letrozole
Vinblastine
Vinorelbine